Partial duplication/triplication of chromosome 5 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:262211
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial duplication/triplication of chromosome 5 syndrome (Orphanet code 262211) refers to a group of rare chromosomal anomalies in which a segment of chromosome 5 is present in extra copies — either duplicated (resulting in three copies of that segment) or triplicated (resulting in four copies). The clinical presentation is highly variable and depends on the size and specific location of the duplicated or triplicated region along chromosome 5, as well as whether the rearrangement is de novo or inherited. Because chromosome 5 contains numerous genes involved in development, these extra copies can disrupt normal growth and organ formation. Affected individuals may present with intellectual disability, developmental delay, growth abnormalities, dysmorphic facial features, and congenital malformations involving multiple organ systems including the heart, brain, kidneys, and skeletal system. Hypotonia, feeding difficulties in infancy, and speech and language delays are also commonly reported. The severity of symptoms can range from mild learning difficulties to significant multi-system involvement depending on the specific chromosomal segment involved. For example, duplications involving the proximal long arm (5q) may have different clinical consequences than those involving the short arm (5p). There is no specific cure or targeted therapy for partial duplication or triplication of chromosome 5. Management is supportive and symptom-based, typically involving a multidisciplinary team including pediatricians, geneticists, cardiologists, neurologists, and developmental specialists. Early intervention programs addressing speech, occupational, and physical therapy are important components of care. Genetic counseling is recommended for affected families to assess recurrence risk, particularly when a parent carries a balanced chromosomal rearrangement that predisposes to unbalanced offspring.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial duplication/triplication of chromosome 5 syndrome.

View clinical trials →

No actively recruiting trials found for Partial duplication/triplication of chromosome 5 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial duplication/triplication of chromosome 5 syndrome community →

No specialists are currently listed for Partial duplication/triplication of chromosome 5 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial duplication/triplication of chromosome 5 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial duplication/triplication of chromosome 5 syndromeForum →

No community posts yet. Be the first to share your experience with Partial duplication/triplication of chromosome 5 syndrome.

Start the conversation →

Latest news about Partial duplication/triplication of chromosome 5 syndrome

No recent news articles for Partial duplication/triplication of chromosome 5 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial duplication/triplication of chromosome 5 syndrome

What is Partial duplication/triplication of chromosome 5 syndrome?

Partial duplication/triplication of chromosome 5 syndrome (Orphanet code 262211) refers to a group of rare chromosomal anomalies in which a segment of chromosome 5 is present in extra copies — either duplicated (resulting in three copies of that segment) or triplicated (resulting in four copies). The clinical presentation is highly variable and depends on the size and specific location of the duplicated or triplicated region along chromosome 5, as well as whether the rearrangement is de novo or inherited. Because chromosome 5 contains numerous genes involved in development, these extra copies

At what age does Partial duplication/triplication of chromosome 5 syndrome typically begin?

Typical onset of Partial duplication/triplication of chromosome 5 syndrome is neonatal. Age of onset can vary across affected individuals.